Exhibit 10(t)


 


THIRD AMENDMENT TO REVOLVING LOAN
AND SECURITY AGREEMENT


 


Third Amendment
to Revolving Loan and Security Agreement (“Amendment”) dated as of October 31, 2015 by and among ENZO
BIOCHEM, INC., a New York corporation (“Enzo”), ENZO CLINICAL LABS, INC., a New York
corporation (“Enzo Clinical Labs”), ENZO LIFE SCIENCES, INC., a New York corporation
(“Enzo Life Sciences”), AXXORA, LLC, a Delaware limited liability company
(“Axxora”), ENZO REALTY LLC, a New York limited liability company (“Enzo
Realty”, together with Enzo, Enzo Clinical Labs, Enzo Life Sciences, Axxora and each other Person joined to the
Loan Agreement (as defined below) as a borrower from time to time, collectively, the “Borrowers” and each
a “Borrower”), ENZO THERAPEUTICS, INC., a New York corporation, as a Guarantor
(“Enzo Therapeutics”, together with Borrowers, the “Loan Parties” and each a
“Loan Party”), HFG-HEALTHCO-4 TRUST, a Delaware statutory trust (f/k/a HFG-Healthco-4, LLC,
“HFG-4”), in its capacity as a Lender (together with any other financial institutions party to the Loan
Agreement as a lender, the “Lenders”), and MIDCAP FINANCIAL TRUST, a Delaware statutory trust and
assignee of Healthcare Finance Group, LLC, as administrative agent and collateral agent for the Lenders (together with its
successors and permitted assigns in such capacities, the “Agent”).


 


BACKGROUND


 


A. Loan Parties, Lenders and Agent entered
into that certain Revolving Loan and Security Agreement dated as of June 7, 2013 (together with all existing and future amendments,
restatements, modifications, extensions, consolidations and substitutions, the “Loan Agreement”), and certain
related “Loan Documents” (as defined in the Loan Agreement) evidencing certain financing arrangements among Agent,
Lenders and Loan Parties as more particularly described therein. All capitalized terms used herein and not defined herein shall
have the meanings ascribed to such terms in the Loan Agreement.


 


B. Loan Parties have requested, and Lenders
and Agent have agreed, to amend certain provisions of the Loan Agreement, in each case on the terms and conditions set forth herein.


 


NOW THEREFORE, with the foregoing Background
deemed incorporated by reference in this Amendment and for good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the parties hereto, intending to be legally bound, covenant and agree as follows:


 


1. AMENDMENTS. Upon the effectiveness
of this Amendment, the Loan Agreement shall be amended as follows:


 


(i) Definitions. The definition
of “Cash Burn” contained in Section 1.1 of the Loan Agreement shall be amended and restated in its entirety
as follows:


 


“Cash Burn” means for
any period or as of any date, in each case with respect to the Loan Parties and their Subsidiaries on a consolidated basis, EBITDA
plus to the extent deducted from net income in calculating EBITDA, all expenses of Loan Parties relating to research and
development and legal costs, minus the sum of the following items to the extent actually paid in cash during such period,
determined



    	 



    	



    



in each case in accordance with GAAP: (i)
the greater of (x) scheduled principal payments of long term Debt and Capital Leases to be made during such period and (y) actual
principal payments of long term Debt and Capital Leases made during such period, (ii) if Liquidity as of the last day of the fiscal
quarter for which Cash Burn is being tested is less than or equal to $7,000,000, Capital Expenditures made during such period (to
the extent not funded by permitted purchase money loans or Capital Leases), (iii) interest expense during such period (including
that portion attributable to Capital Leases in accordance with GAAP and capitalized interest), (iv) taxes during such period based
on the Loan Parties’ and their Subsidiaries income, (v) the aggregate amount of Distributions, and other advances, and loans
to officers, Affiliates, and shareholders made during such period, and (vi) any required minimum pension plan payments. For the
avoidance of doubt, if Liquidity as of the last day of the fiscal quarter for which Cash Burn is being tested is greater than $7,000,000,
Capital Expenditures for such period shall not be deducted from EBITDA in calculating Cash Burn.


 


(ii) Definitions. The definition
of “Liquidity” shall be added to Section 1.1 of the Loan Agreement in the appropriate alphabetical order:


 


“Liquidity” means an
amount equal to the sum of (1) the aggregate amount of cash on the most recent balance sheet delivered to Agent pursuant to Section
8.5 hereof, plus (2) the positive difference, if any between (A) the Adjusted Borrowing Limit and (B) the sum of the then Outstanding
Balance of the Revolving Loan.


 


2. EFFECTIVENESS CONDITIONS.
The effectiveness of this Amendment is conditioned upon the satisfaction of each of the conditions set forth below (as determined
by Agent in its sole discretion) (the “Effectiveness Conditions”):


 


(a) Execution and delivery of this Amendment
by the parties hereto;


 


(b) Receipt of an amendment fee of $15,000.00
which fee is fully earned and due and payable as of the date hereof;


 


(c) No Default or Event of Default shall
have occurred and be continuing;


 


(d) Receipt by Agent of such other documents,
instruments, agreements or information as may otherwise be or have been reasonably requested by Agent; and


 


(e) Payment of any and all costs, fees
and expenses of Agent and Lenders, including reasonable attorneys’ fees, in connection with this Amendment and the transactions
contemplated hereby.


 


3. REPRESENTATIONS AND WARRANTIES.
Each Loan Party represents, warrants and acknowledges to Lenders and Agent as follows:






    	2



    	



    

(a) It is duly formed, organized, validly
existing and in good standing under the laws of its jurisdiction of organization or incorporation and is in good standing in every
jurisdiction where the nature of its business requires it to be so qualified.


 


(b) This Amendment has been duly executed
and delivered by such Loan Party and is in full force and effect as of the date hereof and constitutes the legal, valid and binding
obligations of such Loan Party, enforceable against such Loan Party in accordance with its terms;


 


(c) Such Loan Party has taken all necessary
authorizing action to authorize the execution, delivery, and performance of this Amendment and each document, instrument and agreement
to be delivered in connection herewith;


 


(d) The execution, delivery and performance
by each Loan Party of this Amendment and the Loan Documents to which it is a party and any other documents delivered or to be delivered
by it thereunder (i) are within its corporate powers; (ii) have been duly authorized by all necessary corporate, limited liability
company or partnership action, as applicable; (iii) do not contravene its organizational documents, any material law, rule, or
regulation applicable to it (including, without limitation, laws, rules and regulations relating to usury, truth in lending, fair
credit billing, fair credit reporting, equal credit opportunity, fair debt collection practices, licensing, and privacy), any provision
of any contractual restriction binding on or affecting it or any material portion of its Property, or any order, writ, judgment,
award, injunction or decree binding on or affecting it or its Property; and (iv) do not and will not result in any default, noncompliance,
suspension, revocation, impairment, forfeiture or non-renewal of any permit, license, authorization or approval applicable to its
operations or any of its Properties;


 


(e) All warranties and representations
made to Agent and/or Lenders under the Loan Agreement and the Loan Documents (as and if specifically amended herein) are true and
correct in all material respects (except for representations and warranties qualified by materiality or Material Adverse Effect,
which shall be true in all respects) as of the date hereof (except any representation or warranty that expressly indicates that
it is being made as of a specified date, in which case each such representation or warranty is true and correct as of the date
specified).


 


4. REAFFIRMATION. Except
as expressly amended hereby, all of the terms and conditions of the Loan Agreement and the other Loan Documents are hereby ratified
and confirmed and continue unchanged and in full force and effect. This Amendment shall be deemed incorporated into and made a
part of the Loan Agreement, and all references to the Loan Agreement in any Loan Document (including the Loan Agreement) shall
mean the Loan Agreement as modified by this Amendment. The Loan Documents and this Amendment shall be construed as integrated and
complementary of each other, and as augmenting and not restricting Agent’s and/or Lender’s rights, remedies and security.
If, after applying the foregoing, an inconsistency still exists, the provisions of this Amendment shall control. Each Loan Party
hereby also confirms and ratifies in all respects the Lender Debt outstanding under the Loan Documents, and acknowledges that the
Loan Documents shall continue in full force and effect as therein written except as amended hereby and that no claims, counterclaims,
offsets or defenses arising out of or with respect to the Lender Debt under the Loan Documents exist. Each Loan



    	3



    	



    

Party hereby confirms that all security
interests at any time granted by it to Agent continue in full force and effect and secure and shall continue to secure the Lender
Debt, so long as any such liabilities or obligations remain outstanding and that all property subject thereto remain free and clear
of any liens or encumbrances other than Permitted Liens. Nothing herein contained is intended to in any manner impair or limit
the validity, priority and extent of Agent’s existing security interest in and liens upon the Collateral.


 


5. RESERVED.


 


6. MISCELLANEOUS.


 


(a) Counterparts. This Amendment
may be executed in any number of counterparts and by different parties on separate counterparts (including by facsimile or email
transmission of executed signature pages hereto), each of which counterparts, when so executed and delivered, shall be deemed to
be an original and all of which counterparts, taken together, shall constitute but one and the same Amendment. Signature by facsimile
or other electronic transmission (including PDF) shall bind the parties hereto.


 


(b) Third-Party Rights. No rights
are intended to be created hereunder for the benefit of any third-party donee, creditor or incidental beneficiary or any affiliate
of any Borrower.


 


(c) Modifications. No modification
hereof or any agreement referred to herein shall be binding or enforceable unless in writing and signed on behalf of the party
against whom enforcement is sought.


 


(d) Headings. The headings of any
paragraph of this Amendment are for convenience only and shall not be used to interpret any provision of this Amendment.


 


(e) Survival. All warranties, representations
and covenants made by Borrowers herein, or in any agreement referred to herein or on any certificate, document or other instrument
delivered by them or on their behalf under this Amendment, shall be considered to have been relied upon by Agent and Lenders. All
statements in any such certificate or other instrument shall constitute warranties and representations by Loan Parties hereunder.
All warranties, representations, indemnities and covenants made by Loan Parties hereunder or under any other agreement or instrument
shall be deemed continuing until the Lender Debt is indefeasibly paid and satisfied in full.


 


(f) Further Assurances. The parties
hereto shall execute and deliver such additional documents and take such additional action, as may be reasonably necessary or desirable
to effectuate the provisions and purposes of this Amendment.


 


(g) Successors and Assigns. This
Amendment shall inure to the benefit of and be binding upon the successors and assigns of each of the parties hereto. No delegation
by Borrowers of any duty or obligation of performance may be made or is intended to be made to Lender.



    	4



    	



    

(h) GOVERNING LAW. THIS AMENDMENT
AND ALL MATTERS ARISING OUT OF OR RELATED TO THIS AGREEMENT, SHALL, IN ACCORDANCE WITH SECTION 5-1401 OF THE GENERAL OBLIGATIONS
LAW OF THE STATE OF NEW YORK, BE GOVERNED BY THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO ANY CONFLICTS OF LAWS PRINCIPLES
THEREOF THAT WOULD CALL FOR THE APPLICATION OF THE LAWS OF ANY OTHER JURISDICTION, EXCEPT TO THE EXTENT THAT THE VALIDITY OR PERFECTION
OF THE SECURITY INTERESTS GRANTED HEREUNDER, OR REMEDIES RELATED THERETO, IN RESPECT OF ANY PARTICULAR COLLATERAL ARE GOVERNED
BY THE LAWS OF A JURISDICTION OTHER THAN THE STATE OF NEW YORK.


 


(i) WAIVER OF JURY TRIAL, JURISDICTION
AND VENUE. EACH OF THE PARTIES HERETO HEREBY WAIVES ALL RIGHTS TO A TRIAL BY JURY IN THE EVENT OF ANY LITIGATION WITH RESPECT
TO ANY MATTER RELATED TO THIS AMENDMENT, AND HEREBY IRREVOCABLY CONSENTS TO THE JURISDICTION OF THE STATE AND FEDERAL COURTS LOCATED
IN NEW YORK COUNTY, NEW YORK CITY, NEW YORK IN CONNECTION WITH ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AMENDMENT.
IN ANY SUCH LITIGATION, EACH OF THE PARTIES HERETO WAIVES PERSONAL SERVICE OF ANY SUMMONS, COMPLAINT OR OTHER PROCESS AND AGREES
THAT SERVICE THEREOF MAY BE MADE BY CERTIFIED OR REGISTERED MAIL DIRECTED TO THE PARTIES HERETO AT THEIR ADDRESSES SET FORTH ON
SCHEDULE I TO THE LOAN AGREEMENT.


 


[SIGNATURES TO APPEAR ON FOLLOWING PAGE]



    	5



    	



    

IN WITNESS
WHEREOF, the parties have caused this Agreement to be executed by their respective officers thereunto duly authorized, as of the
date first above written.


 


	BORROWERS:	ENZO BIOCHEM, INC.	 
	 	 	 
	 	By:	/s/ James O’Brien	 
	 	Name:	James O’Brien	 
	 	Title:	EVP Finance	 
	 	 	 	 
	 	ENZO CLINICAL LABS, INC.	 
	 	 	 
	 	By:	/s/ James O’Brien	 
	 	Name: 	James O’Brien	 
	 	Title:	EVP Finance	 
	 	 	 	 
	 	ENZO LIFE SCIENCES, INC.	 
	 	 	 
	 	By:	/s/ James O’Brien	 
	 	Name: 	James O’Brien	 
	 	Title:	EVP Finance	 
	 	 	 	 
	 	AXXORA, LLC	 
	 	 	 
	 	By:	/s/ James O’Brien	 
	 	Name:	James O’Brien	 
	 	Title:	EVP Finance	 
	 	 	 	 
	 	ENZO REALTY LLC	 
	 	 	 
	 	By:	/s/ James O’Brien	 
	 	Name:	James O’Brien	 
	 	Title:	EVP Finance	 
	 	 	 	 
	GUARANTOR:	ENZO THERAPEUTICS, INC.	 
	 	 	 
	 	By:	/s/ James O’Brien	 
	 	Name:	James O’Brien	 
	 	Title:	EVP Finance	 


 


[SIGNATURE
PAGE TO THIRD AMENDMENT AND WAIVER]



    	S-1



    	



    

	 	Agent:	 
	 	 	 
	 	MIDCAP FINANCIAL TRUST, assignee of Healthcare
    Finance Group, LLC, acting as administrative agent and collateral agent on behalf of Lender pursuant to Section 12.3 of the
    Loan Agreement	 
	 	 	 
	 	By:	Apollo Capital Management, L.P.,

its investment manager	 
	 	 	 	 
	 	By:	Apollo Capital Management GP, LLC,

its general partner	 
	 	 	 	 
	 	 	By:	/s/ Maurice Amsellem	 
	 	 	Name:	Maurice Amsellem	 
	 	 	Title:	Authorized Signatory	 
	 	 	 	 	 
	 	Lenders:	 
	 	 	 
	 	HFG HEALTHCO-4 TRUST, as Revolving Lender	 
	 	 	 
	 	By:	Apollo Capital Management, L.P.,

its investment manager	 
	 	 	 	 
	 	By:	Apollo Capital Management GP, LLC,

its general partner	 
	 	 	 	 
	 	 	By:	/s/ Maurice Amsellem	 
	 	 	Name:	Maurice Amsellem	 
	 	 	Title:	Authorized Signatory	 


 


[SIGNATURE
PAGE TO THIRD AMENDMENT AND WAIVER]


    	S-2